A positive HPV test result has the potential to cause anxiety. This blog is about research taking place into how women feel about receiving such a result.
We have published new guidance for local cervical screening providers on implementing high-risk human papillomavirus (hrHPV) testing as the programme’s primary screening test.
A blog by Rob Music, chief executive of Jo’s Cervical Cancer Trust, as part of Cervical Cancer Prevention Week (21 to 27 January 2019).
In 2016 it was announced that HPV primary screening will be rolled out in the cervical screening programme across the whole of England by 2020. Find out about latest developments.
PHE has published guidance describing the role and responsibilities of cervical screening provider leads.
Ruth Stubbs, PHE's Cervical Screening Programme Manager, shares how the plans for introducing HPV primary screening are coming along.
PHE Screening has published guidance for laboratories and local cervical screening providers to support the option of mitigating against the risk of longer cytology backlogs by using primary HPV screening pilot sites.
NHS England has published a statement regarding commissioning decisions for HPV primary screening in the cervical screening programme.
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
Evidence shows that human papillomavirus (HPV) testing is a better way of identifying women at risk of cervical cancer than the cytology (smear) test that examines cells under a microscope.